Just a few more days and AEMD gets IDE approval and next round of gov't funding, Aemd gets noticed, todays closing will have the period moved back two positions to the right! Don't fall prey to the Winter winds that blow from Navada! Patents have real value. Big Pharm will probably buy REAL soon. I'm picking up shares at my trigger points daily, Go Longs, we will soon be deciding on what exit point for a portion,and what to keep for the kids.
Has anyone read up on the FDA breakthrough therapy program within the FDA? It reads as though it is for drugs only and not for devices, but the HP certainly applies as "breakthrough". See exerpt from FDA website:
"If the breakthrough therapy designation request is submitted to the sponsor’s IND as an amendment, the cover letter should indicate the submission as a REQUEST FOR BREAKTHROUGH THERAPY DESIGNATION in bold, uppercase letters. If the request is submitted with an initial IND, the cover letter should indicate the submission as both an INITIAL INVESTIGATIONAL NEW DRUG SUBMISSION and REQUEST FOR BREAKTHROUGH THERAPY DESIGNATION in bold, uppercase letters."